secwatch.observer — SEC 8-K summary
======================================

Issuer:     WYNDHAM HOTELS & RESORTS, INC. (WH)
CIK:        0001722684
Form:       8-K
Filed at:   2026-05-18T10:36:33+00:00
Accession:  0001140361-26-021771
Event type: leadership
Sentiment:  negative
Materiality: 0.65
Item codes: 8.01, 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Wyndham CEO Ballotti diagnosed with multiple myeloma; CAO Rossi to depart, Androski to succeed
--------------------------------------------------------------------------------

- CEO Geoff Ballotti diagnosed with multiple myeloma (treatable bone cancer); prognosis favorable, treatment at Dana-Farber; he plans to continue working largely as normal with reduced travel.
- Chief Accounting Officer Nicola Rossi to depart on July 31, 2026; Christopher Androski (current SVP and Controller) will succeed as CAO.
- At May 14 annual meeting, all nine director nominees elected; advisory say-on-pay approved with 85% of votes cast; Deloitte ratified as auditor.
- Stockholder proposal on ability to act by written consent passed with approx 63% of votes in favor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1722684/000114036126021771/0001140361-26-021771-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1722684/000114036126021771/ef20073914_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-021771

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer